UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000063678
Receipt number R000072779
Scientific Title Study to Assess Facial and Hand Conditions Across Age Groups
Date of disclosure of the study information 2026/11/22
Last modified on 2026/11/11 17:38:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study to Assess Facial and Hand Conditions Across Age Groups

Acronym

Study to Assess Facial and Hand Conditions Across Age Groups

Scientific Title

Study to Assess Facial and Hand Conditions Across Age Groups

Scientific Title:Acronym

Study to Assess Facial and Hand Conditions Across Age Groups

Region

Japan


Condition

Condition

Age-related changes in the face and hands

Classification by specialty

Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate age-related changes in the face and hands through imaging and measurements using various instruments in participants across different age groups.

Basic objectives2

Others

Basic objectives -Others

Assessment of age-related changes in skin properties and gene expression in the face and hands

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To evaluate age-related changes in skin viscoelasticity, transepidermal water loss, skin color, gene expression, and other parameters in the facial and hand regions.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

69 years-old >=

Gender

Female

Key inclusion criteria

1 Individuals who have received and understood an explanation of the study and voluntarily provided informed consent to participate.
2 Healthy Japanese women aged 20 to 69 years.
3 Individuals who can understand spoken and written Japanese and complete documents, including the informed consent form, in Japanese.
4 Individuals who have not undergone cosmetic procedures, such as laser treatment, radiofrequency treatment, hyaluronic acid injections, or thread lifts, on the face, backs of the hands, fingers, or nails since May 25, 2026.
5 Individuals who have not undergone nail surface buffing or applied gel nails, nail polish, artificial nail tips, or other nail decorations, either at home or at a nail salon, since August 25, 2026.
6 Individuals who can provide information on the cosmetics, quasi-drugs, health foods, and medications they regularly use.
7 Individuals who can provide information on their usual lifestyle habits and any cosmetic procedures undergone within the past year.
8 Individuals who can attend the designated study site on the scheduled assessment date.

Key exclusion criteria

1 Individuals with injuries, inflammation, or other symptoms at the study sites that could affect the study.
2 Individuals who are pregnant, may be pregnant, are breastfeeding, or plan to become pregnant during the study participation period.
3 Individuals who are allergic to alcohol-based disinfectants or rubber.
4 Individuals with a history of atopic dermatitis.
5 Individuals with a history of photosensitivity.
6 Individuals receiving hormone replacement therapy.
7 Individuals with severe anemia.
8 Individuals prone to keloid formation (i.e., those whose scars tend to become red and raised and are difficult to heal).
9 Individuals with diabetes mellitus.
10 Individuals using antithrombotic medications.
11 Individuals with cold symptoms or a body temperature of 37.5 or higher on the day of the study visit.
12 Individuals otherwise deemed unsuitable for participation by the study physician or study personnel.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Wakako
Middle name
Last name Inoue

Organization

Yawara Dermatology Clinic

Division name

Dermatology

Zip code

530-0041

Address

4F, Sakashin Tenjinbashi Building, 5-7-10 Tenjinbashi, Kita-ku, Osaka, Japan

TEL

06-6881-1000

Email

ethics_board@drc-web.co.jp


Public contact

Name of contact person

1st name Fumiya
Middle name
Last name Yamaji

Organization

POLA Chemical Industries, Inc

Division name

Frontier Research Center

Zip code

2440812

Address

560 Kashio-cho, Totsuka-ku, Yokohama, Kanagawa, Japan

TEL

0458267232

Homepage URL


Email

f-yamaji@pola.co.jp


Sponsor or person

Institute

DRC Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

POLA Chemical Industries, Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Brain Care Clinic Ethics Committee

Address

2F, Shiratori Building, 2-1-2 Shinjuku, Shinjuku-ku, Tokyo 160-0022, Japan

Tel

03-6273-2214

Email

ethics_board@drc-web.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 11 Month 05 Day

Date of IRB


Anticipated trial start date

2026 Year 11 Month 24 Day

Last follow-up date

2026 Year 11 Month 27 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Assessment of age-related changes in skin properties and gene expression in the face and hands


Management information

Registered date

2026 Year 11 Month 18 Day

Last modified on

2026 Year 11 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072779